A randomized comparative study on rectal versus oral Diclofenac for perineal pain relief following episiotomy repair in a tertiary hospital

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

PACTR

Registry ID

PACTR202308864630455

Enrollment

132

Registered

2023-08-10

Start date

2023-08-25

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Episiotomy pain

Interventions

Oral diclofenac and rectal placebo

Oral placebo and rectal diclofenac

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1. All parturients who will have episiotomy repair following delivery. 2. Live foetuses 3. All booked consenting women whose consent will be revalidated during labou

Exclusion criteria

Exclusion criteria: 1.Women with contraindications to NSAIDS e.g. peptic ulcer, liver disease, renal disease, bronchial asthma. 2. Women who will have 3rd or 4th-degree perineal tear 3. Women with severe primary postpartum haemorrhage >1000mls. 4. Any patient that would require specialized post- delivery pain control such as Sickle cell disease patients

Design outcomes

Primary

Measure	Time frame
The difference in the mean pain score/ median between the two groups (rectal versus oral) in perineal pain relief following episiotomy repair	—

Secondary

Measure	Time frame
The secondary outcome variables include the mean time interval for the need for additional analgesia, frequency of additional (rescue) analgesia requested, the mean time interval between drug administration and voiding of first urine and the proportion of maternal satisfaction for the route of drug administration	—

Countries

Nigeria

Contacts

Public ContactPeter Awoyesuku

Public enquiries

pawoyesuku@yahoo.com+2348033389988

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026